[swaghmare]

Up

1

Down

::

During the COVID-19 pandemic, monoclonal antibodies were utilized to destroy the virus by blocking its ability to bind to protein receptors in the human body. This new approach has inspired scientists to explore the use of monoclonal antibodies in treating chronic pain, as they offer a more sustainable and effective solution compared to traditional pain management strategies such as opioids and NSAIDs.
While opioids provide temporary pain relief, they often lose their efficacy over time and can lead to harmful side effects such as addiction, tolerance, and even life-threatening respiratory distress. On the other hand, monoclonal antibodies last longer in the body, potentially providing sustained pain relief for several weeks, as opposed to just hours or days with opioids.
The use of monoclonal antibodies in pain management is promising for individuals with chronic conditions such as osteoarthritis, rheumatoid arthritis, lower back pain, neuropathic pain, or cancer-related pain. These antibodies would be designed to target specific ion channels on nerve cells responsible for receiving signals caused by painful stimuli, effectively shutting off the transmission of chronic pain.
https://www.nationalgeographic.com/magazine/article/could-this-be-the-solution-to-chronic-pain-opioid-crisis-monoclonal-antibody
fremanezumab – medtigo
eptinezumab – medtigo

• This topic was modified 1 month, 3 weeks ago by swaghmare.

[Robert Schwartz]

Up

0

Down

::

My concern with pain relief is the masking of the deriving factor of why is their pain. Use of natural occurring forms of our innate abilities is a part of our auto immune defense. Identify the binding molecules that promotes the uses of antibodies and how other replacement therapy may offset the advantage of our adaptive immunity. I prefer diet and exercise that through proper channels make us less dependent on pharmaceutical remedies.

[Pranad Kshirsagar]

Up

0

Down

::

I believe pharmaceuticals are required in conditions with chronic pain. Monoclonal antibodies can ease the pain if it is developed to target pain signals,

[Shannon Christian]

Up

0

Down

::

It would be alot better than most options for pain control. And with migraines, anything new is very appreciated for tx.

[aishatusnasara9]

Up

0

Down

::

swaghmare wrote:

During the COVID-19 pandemic, monoclonal antibodies were utilized to destroy the virus by blocking its ability to bind to protein receptors in the human body. This new approach has inspired scientists to explore the use of monoclonal antibodies in treating chronic pain, as they offer a more sustainable and effective solution compared to traditional pain management strategies such as opioids and NSAIDs.
While opioids provide temporary pain relief, they often lose their efficacy over time and can lead to harmful side effects such as addiction, tolerance, and even life-threatening respiratory distress. On the other hand, monoclonal antibodies last longer in the body, potentially providing sustained pain relief for several weeks, as opposed to just hours or days with opioids.
The use of monoclonal antibodies in pain management is promising for individuals with chronic conditions such as osteoarthritis, rheumatoid arthritis, lower back pain, neuropathic pain, or cancer-related pain. These antibodies would be designed to target specific ion channels on nerve cells responsible for receiving signals caused by painful stimuli, effectively shutting off the transmission of chronic pain.
https://www.nationalgeographic.com/magazine/article/could-this-be-the-solution-to-chronic-pain-opioid-crisis-monoclonal-antibody
fremanezumab – medtigo
eptinezumab – medtigo

• This topic was modified 1 month, 3 weeks ago by swaghmare.

[Author]

Posts